Effect of serum components on the physico-chemical properties of cationic lipid/oligonucleotide complexes and on their interactions with cells.
about
Drug delivery trends in clinical trials and translational medicine: challenges and opportunities in the delivery of nucleic acid-based therapeuticsIn vivo gene targeting of IL-3 into immature hematopoietic cells through CD117 receptor mediated antibody gene deliveryCurrent progress in gene delivery technology based on chemical methods and nano-carriersThe characterization of cationic fusogenic liposomes mediated antisense oligonucleotides into HeLa cells.Optimizing cationic and neutral lipids for efficient gene delivery at high serum content.Efficient delivery of plasmid DNA using cholesterol-based cationic lipids containing polyamines and ether linkages.The effect of N/P ratio on the in vitro and in vivo interaction properties of PEGylated poly[2-(dimethylamino)ethyl methacrylate]-based siRNA complexes.Biophysical and transfection studies of the diC(14)-amidine/DNA complex.Delivery of novel macromolecular drugs against HIV-1.Vehicles for oligonucleotide delivery to tumours.Imaging of cationic multifunctional liposome-mediated delivery of COX-2 siRNA.Cholesterol domains enhance transfectionThe effects of lipoplex formulation variables on the protein corona and comparisons with in vitro transfection efficiencyCalcium-activated gene transfection from DNA/poly(amic acid-co-imide) complexes.Polyanions and the proteome.Nanoparticle-mediated gene delivery: state of the art.Effects of the incorporation of a hydrophobic middle block into a PEG-polycation diblock copolymer on the physicochemical and cell interaction properties of the polymer-DNA complexes.Incorporation of DOPE into Lipoplexes formed from a Ferrocenyl Lipid leads to Inverse Hexagonal Nanostructures that allow Redox-Based Control of Transfection in High Serum.Influence of nano-carrier architecture on in vitro siRNA delivery performance and in vivo biodistribution: polyplexes vs micelleplexes.A novel EGFR-targeted gene delivery system based on complexes self-assembled by EGF, DNA, and activated PAMAM dendrimers.Synthetic, self-assembly ABCD nanoparticles; a structural paradigm for viable synthetic non-viral vectors.Cell biological and biophysical aspects of lipid-mediated gene delivery.Gene delivery through cell culture substrate adsorbed DNA complexes.Cell-penetrating peptides as delivery vehicles for biology and medicine.Particle-mediated Intravenous Delivery of Antigen mRNA Results in Strong Antigen-specific T-cell Responses Despite the Induction of Type I InterferonGene delivery to the rat liver using cationic lipid emulsion/DNA complex: comparison between intra-arterial, intraportal and intravenous administration.PEGylated cationic liposome-DNA complexation in brine is pathway-dependent.Recent advances in tumor vasculature targeting using liposomal drug delivery systems.Pharmaceutical emulsions: a new approach for gene therapy.Targeting anticancer drugs to tumor vasculature using cationic liposomes.Cationic nanoparticles for cancer therapy.Smart drug delivery nanocarriers with self-assembled DNA nanostructures.New views and insights into intracellular trafficking of drug-delivery systems by fluorescence fluctuation spectroscopy.Inorganic nanovectors for nucleic acid delivery.Synthetic vectors for gene delivery: An overview of their evolution depending on routes of administration.A low-molecular-weight heparin-coated doxorubicin-liposome for the prevention of melanoma metastasis.Cationic lipid guided short-hairpin RNA interference of annexin A2 attenuates tumor growth and metastasis in a mouse lung cancer stem cell modelEnhanced hepatic delivery of siRNA and microRNA using oleic acid based lipid nanoparticle formulationsLipid Nanovectors to Deliver RNA Oligonucleotides in Cancer.The effect of cholesterol domains on PEGylated liposomal gene delivery in vitro
P2860
Q24616751-C78769F7-761D-4AAB-B04B-0A818F5C1750Q24801425-44A130BF-C956-4BDE-AEA0-20E7969A25C4Q28659480-CAAA4D33-725F-4A74-8AE0-F97894D4B098Q33201731-842374A0-E3DF-4B2C-B505-0556A5E773D1Q33732824-9CBE3EF0-3DF1-4B89-A40B-60EA04442A6CQ33755551-719999B8-3078-4A62-B260-25A070819586Q33999411-D78C9AD4-28D5-4FEA-B4F0-1EB8755B6854Q34178100-EAAC5CA0-0368-4E53-A12B-66635F619A77Q34452681-2AE725D4-A384-49C2-A74E-927CEBAC16A7Q34518719-212CAC8F-78DE-4376-88F1-8800ED56306CQ34640040-3DE51BF3-9A1E-44B7-85B6-8AC5F14AE13BQ34655402-DB9DF20F-2029-4F59-AE49-2C627454F557Q34899427-3C419137-613E-4485-8ADD-A471EC39F9DCQ35162391-7604B04B-54A6-4AE4-AD68-52D4CCDC5D69Q35773099-E5B0C29D-369B-483F-9AE5-AB4D5E550DAEQ35842597-3D30A86C-F0EA-4B3E-86E7-AFA117C18A56Q35919062-49C8F68B-C6E2-4EBF-BD3B-DC87B9B7B4D0Q36030078-DAC52B6C-B33C-4E5B-AC4E-DE406F67C694Q36052917-967D3813-DBF2-4F2A-B8EE-E4481465222CQ36191332-C1112B04-A14F-447F-99BE-FF80F6391404Q36292965-2C3767FC-0A3F-4BBB-877E-50644FE53D35Q36617965-9DADDEBC-4D2D-4959-A5DC-85C8CBC35AC3Q37110950-FAA917FB-7C6A-443D-8DB2-CF8D0CD9803BQ37194529-BEFFA28A-503C-408C-9B7D-C384857A054DQ37254639-ABBCFE98-C3CC-4EB7-8496-ADFD3FC6FFC5Q37270210-9C6CE25B-92EC-42F2-9D37-595474C6C9F7Q37479258-55D7A547-BB6A-4C4E-BAEB-76A5AEC09834Q37603355-2D774B5B-2601-43E8-A8CE-C3DBBBD595E8Q37643683-88A4CD27-96D5-4D8F-AA3B-57C3FD22226FQ37718056-88832BF3-C247-4219-A244-1A308A91308AQ37743515-62AAEEF2-F197-40FD-BFB7-F9B395B1B56DQ38114373-13EA56A2-8910-43E6-9714-9E300EBB2659Q38183853-7298710C-D58C-4EFC-81E2-A6CAE2E28B78Q38383483-9FF4053E-ECFF-4D7B-ABA9-57E909F64EE5Q38513773-BB3E9AF5-E4B4-4451-B830-672134EA2476Q38925364-1F7C97FD-1B53-47B6-81E7-ABB5C2C897E3Q39004813-33A9C50C-1DB2-40AF-BC49-CD0F3153FF82Q39080011-5816CEE3-E5F9-4A0B-8E98-C29D051AC6F1Q39196485-8DB60015-1AAF-4064-86FC-2D6CB9EAC3E2Q39377390-56D3542D-B6A9-4419-8FB9-A812990E8227
P2860
Effect of serum components on the physico-chemical properties of cationic lipid/oligonucleotide complexes and on their interactions with cells.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Effect of serum components on ...... their interactions with cells.
@en
type
label
Effect of serum components on ...... their interactions with cells.
@en
prefLabel
Effect of serum components on ...... their interactions with cells.
@en
P2093
P1476
Effect of serum components on ...... their interactions with cells.
@en
P2093
L G Barron
L S Uyechi
O Zelphati
P304
P356
10.1016/S0005-2760(97)00169-0
P407
P577
1998-02-01T00:00:00Z